A6L

2,3-dihydroxypropyl (9Z)-octadec-9-enoate

Created:	2018-10-02
Last modified:	2020-06-05

Find Related PDB Entry
7 entries where A6L is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	65
Chiral Atom Count	0
Bond Count	64
Aromatic Bond Count	0

2D diagram of A6L

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2,3-dihydroxypropyl (9Z)-octadec-9-enoate
Synonyms	monoolein
Systematic Name (OpenEye OEToolkits)	2,3-bis(oxidanyl)propyl (~{Z})-octadec-9-enoate
Formula	C₂₁ H₄₀ O₄
Molecular Weight	356.54
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C(C(OCC(CO)O)=O)CCCCCC\C=C/CCCCCCCC
SMILES	CACTVS	3.385	CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO
SMILES	OpenEye OEToolkits	2.0.6	CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)O
Canonical SMILES	CACTVS	3.385	CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO
Canonical SMILES	OpenEye OEToolkits	2.0.6	CCCCCCCC/C=C\CCCCCCCC(=O)OCC(CO)O
InChI	InChI	1.03	InChI=1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9-
InChIKey	InChI	1.03	RZRNAYUHWVFMIP-KTKRTIGZSA-N

Drug Info: DrugBank

DrugBank ID	DB13171
Name	Glyceryl 1-oleate
Groups	experimental
Synonyms	1-oleoylglycerol 1-monoolein MG (18:1/0:0/0:0) 1-oleoyl-rac-glycerol 1-(9Z-octadecenoyl)-rac-glycerol 1-monooleoylglycerol 2,3-dihydroxypropyl oleate 9-Octadecenoic acid, 2,3-dihydroxypropyl ester 1-(9Z)-octadecenoylglycerol Glyceryl monooleate 1-Glyceryl oleate Glyceryl 1-oleate Glyceryl oleate Monoolein 1-monooleoyl-rac-glycerol
Categories	Lipids
CAS number	111-03-5

Related Resource References

Resource Name	Reference
PubChem	12178130
ChEBI	CHEBI:75757

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.